Diisopropylethylamine → (S)-tert-butyl 2-((4-(4-(4-(5-(cyclopropylethynyl)pyrimidin-2-yl)piperazin-1-yl)-1,3,5-triazin-2-ylamino)-1H-pyrazol-1-yl)methyl)morpholine-4-carboxylate
Reaction equation
Cl.[CH:2]1([C:5]#[C:6][C:7]2[CH:8]=[N:9][C:10]([N:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)=[N:11][CH:12]=2)[CH2:4][CH2:3]1.Cl[C:20]1[N:25]=[CH:24][N:23]=[C:22]([NH:26][C:27]2[CH:28]=[N:29][N:30]([CH2:32][C@H:33]3[O:38][CH2:37][CH2:36][N:35]([C:39]([O:41][C:42]([CH3:45])([CH3:44])[CH3:43])=[O:40])[CH2:34]3)[CH:31]=2)[N:21]=1.C(N(C(C)C)CC)(C)C>>[CH:2]1([C:5]#[C:6][C:7]2[CH:8]=[N:9][C:10]([N:13]3[CH2:14][CH2:15][N:16]([C:20]4[N:25]=[CH:24][N:23]=[C:22]([NH:26][C:27]5[CH:28]=[N:29][N:30]([CH2:32][C@H:33]6[O:38][CH2:37][CH2:36][N:35]([C:39]([O:41][C:42]([CH3:45])([CH3:44])[CH3:43])=[O:40])[CH2:34]6)[CH:31]=5)[N:21]=4)[CH2:17][CH2:18]3)=[N:11][CH:12]=2)[CH2:4][CH2:3]1Participants
Reactant 3
Product 1
Procedure
To a solution of 5-(cyclopropylethynyl)-2-(piperazin-1-yl)pyrimidine HCl salt (172 mg, 0.44 mmol) and (s)-tert-butyl 2-((4-(4-chloro-1,3,5-triazin-2-ylamino)-1H-pyrazol-1-yl)methyl)morpholine-4-carboxylate was added diisopropylethylamine (169 mg, 1.311 mmol), and the reaction mixture was stirred at room temperature. LCMS showed the reaction was completed. The mixture was concentrated, and the residue was purified by silica gel chromatography, eluting with petroleum ether:ethyl acetate=1:2, to afford (S)-tert-butyl 2-((4-(4-(4-(5-(cyclopropylethynyl)pyrimidin-2-yl)piperazin-1-yl)-1,3,5-triazin-2-ylamino)-1H-pyrazol-1-yl)methyl)morpholine-4-carboxylate (240 mg, 94%) as a yellowish solid. MS (ES+): C29H37N11O3 requires: 587, found: 588 [M+H]+.
Workup
- concentrationThe mixture was concentrated
- customthe residue was purified by silica gel chromatography
- washeluting with petroleum ether
Sources & evidence
- ORD record
- ord-50c30914b2e64c34b300847187868483
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09334263B2
Reaction notes
Loading…